rs9282594
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_014324.6(AMACR):c.712C>T(p.Pro238Ser) variant causes a missense change. The variant allele was found at a frequency of 0.00445 in 1,612,120 control chromosomes in the GnomAD database, including 268 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P238L) has been classified as Uncertain significance.
Frequency
Consequence
NM_014324.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
AMACR | NM_014324.6 | c.712C>T | p.Pro238Ser | missense_variant | 4/5 | ENST00000335606.11 | |
C1QTNF3-AMACR | NR_037951.1 | n.1068C>T | non_coding_transcript_exon_variant | 8/9 | |||
AMACR | NM_001167595.2 | c.712C>T | p.Pro238Ser | missense_variant | 4/6 | ||
AMACR | NM_203382.3 | c.551C>T | p.Thr184Ile | missense_variant | 3/4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
AMACR | ENST00000335606.11 | c.712C>T | p.Pro238Ser | missense_variant | 4/5 | 1 | NM_014324.6 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.0238 AC: 3615AN: 151946Hom.: 141 Cov.: 32
GnomAD3 exomes AF: 0.00629 AC: 1578AN: 250676Hom.: 68 AF XY: 0.00474 AC XY: 642AN XY: 135480
GnomAD4 exome AF: 0.00242 AC: 3539AN: 1460056Hom.: 124 Cov.: 31 AF XY: 0.00207 AC XY: 1501AN XY: 726038
GnomAD4 genome ? AF: 0.0239 AC: 3637AN: 152064Hom.: 144 Cov.: 32 AF XY: 0.0229 AC XY: 1700AN XY: 74356
ClinVar
Submissions by phenotype
Alpha-methylacyl-CoA racemase deficiency Benign:2
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Benign, criteria provided, single submitter | clinical testing | Invitae | Feb 01, 2024 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 10, 2015 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
not provided Benign:1
Benign, no assertion criteria provided | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Dec 16, 2015 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at